Institute of Life and Health Engineering, Jinan University, Guangzhou, China.
Cell Cycle. 2019 Dec;18(23):3300-3312. doi: 10.1080/15384101.2019.1674053. Epub 2019 Oct 9.
Lung cancer is the leading cause of cancer-related deaths worldwide. However, tumor suppressor genes remain to be systemically determined for lung cancer. Here we report interferon regulatory factor 8 (), a member of the family of transcription factors, as a potent lung tumor suppressor gene. Expression of IRF8 is frequently diminished in lung tumoral tissues and is associated with prognosis of non-small cell lung cancer (NSCLC) patients. Ectopic expression of IRF8 suppresses the NSCLC cells proliferation and tumorigenic potential . More importantly, forced expression of IRF8 through infection of recombinant virus inhibits lung tumorigenesis in genetically engineered mouse model (GEMM). Mechanistically, IRF8 inhibits AKT signaling and promotes accumulation of P27 protein, which results in senescence of lung cancer cells. Ectopic expression of IRF8 in tumor cells leads to regression of lung cancer tumor nodules in a xenograft tumor model. Our data, therefore, solidly shows IRF8 to be a lung cancer suppressor gene and may denote an opportunity for therapeutic intervention of NSCLC.
肺癌是全球癌症相关死亡的主要原因。然而,用于肺癌的肿瘤抑制基因仍然需要系统地确定。在这里,我们报告干扰素调节因子 8 (IRF8),一种转录因子家族的成员,是一种有效的肺肿瘤抑制基因。IRF8 的表达在肺肿瘤组织中经常减少,并与非小细胞肺癌 (NSCLC) 患者的预后相关。IRF8 的异位表达抑制 NSCLC 细胞的增殖和致瘤潜能。更重要的是,通过感染重组病毒强制表达 IRF8 可抑制遗传工程小鼠模型 (GEMM) 中的肺肿瘤发生。从机制上讲,IRF8 抑制 AKT 信号通路并促进 P27 蛋白的积累,从而导致肺癌细胞衰老。IRF8 在肿瘤细胞中的异位表达可导致异种移植肿瘤模型中肺癌肿瘤结节的消退。因此,我们的数据确凿地表明 IRF8 是一种肺癌抑制基因,可能为 NSCLC 的治疗干预提供机会。